Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Original ArticlesEpidemiology and Outcomes
You have accessRestricted Access

Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study

Meredith C. Foster, Josef Coresh, Joseph V. Bonventre, Venkata S. Sabbisetti, Sushrut S. Waikar, Theodore E. Mifflin, Robert G. Nelson, Morgan Grams, Harold I. Feldman, Ramachandran S. Vasan, Paul L. Kimmel, Chi-yuan Hsu, Kathleen D. Liu and for the CKD Biomarkers Consortium
CJASN November 2015, 10 (11) 1956-1963; DOI: https://doi.org/10.2215/CJN.02590315
Meredith C. Foster
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josef Coresh
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph V. Bonventre
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Venkata S. Sabbisetti
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sushrut S. Waikar
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theodore E. Mifflin
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert G. Nelson
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Morgan Grams
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harold I. Feldman
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramachandran S. Vasan
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul L. Kimmel
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chi-yuan Hsu
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen D. Liu
Due to the number of contributing authors, the affiliations are provided in the .
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Due to the number of contributing authors, the affiliations are provided in the .
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

Background and objectives Liver fatty acid binding protein (L-FABP), kidney injury molecule 1 (KIM-1), N-acetyl-β-d-glucosaminidase (NAG), and neutrophil gelatinase–associated lipocalin (NGAL) are urinary markers of tubular injury that may also be markers of chronic kidney damage. We evaluated the association of these markers with incident ESRD in a community-based sample from the Atherosclerosis Risk in Communities Study.

Design, setting, participants, & measurements This was a matched case-control study of 135 patients with ESRD and 186 controls who were matched on sex, race, kidney function, and diabetes status at baseline (Atherosclerosis Risk in Communities Study visit 4, 1996–1998). Urinary KIM-1 indexed to creatinine (Cr), NAG/Cr, NGAL/Cr, and L-FABP/Cr were measured in stored spot urine samples from the baseline examination. Associations of KIM-1/Cr, NAG/Cr, and NGAL/Cr with patients with incident ESRD through 2008 were modeled continuously and categorically (quartiles) using conditional logistic regression. L-FABP/Cr was modeled only categorically because of a large number of measurements below the lower limit of detection for the assay (2.4 ng/ml).

Results No significant associations were observed for NAG/Cr, NGAL/Cr, or L-FABP/Cr with ESRD. Those in the highest category for KIM-1/Cr had a higher risk of ESRD compared with those with undetectable biomarker levels (reference group) in unadjusted models (odds ratio, 2.24; 95% confidence interval, 1.97 to 4.69; P=0.03) or adjustment for age (odds ratio, 2.23; 95% confidence interval, 1.06 to 4.67; P=0.03). This association was attenuated with additional adjustment for baseline kidney function (odds ratio, 2.02; 95% confidence interval, 0.95 to 4.31; P=0.07 after additional adjustment for eGFR and natural log of the urinary albumin-to-creatinine ratio). No association between KIM-1/Cr and ESRD was found when KIM-1/Cr was analyzed as a continuous variable.

Conclusions Elevated urinary KIM-1/Cr may be associated with a higher risk of incident ESRD, but it does not add to risk prediction after accounting for traditional markers of kidney function in this population.

  • albuminuria
  • chronic kidney disease
  • end-stage renal disease
  • acetylglucosaminidase
  • diabetes mellitus
  • fatty acid-binding proteins
  • kidney failure
  • chronic
  • lipocalins
  • renal insufficiency
  • chronic
  • Received March 5, 2015.
  • Accepted August 5, 2015.
  • Copyright © 2015 by the American Society of Nephrology
View Full Text
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 10 (11)
Clinical Journal of the American Society of Nephrology
Vol. 10, Issue 11
November 06, 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study
Meredith C. Foster, Josef Coresh, Joseph V. Bonventre, Venkata S. Sabbisetti, Sushrut S. Waikar, Theodore E. Mifflin, Robert G. Nelson, Morgan Grams, Harold I. Feldman, Ramachandran S. Vasan, Paul L. Kimmel, Chi-yuan Hsu, Kathleen D. Liu, for the CKD Biomarkers Consortium
CJASN Nov 2015, 10 (11) 1956-1963; DOI: 10.2215/CJN.02590315

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study
Meredith C. Foster, Josef Coresh, Joseph V. Bonventre, Venkata S. Sabbisetti, Sushrut S. Waikar, Theodore E. Mifflin, Robert G. Nelson, Morgan Grams, Harold I. Feldman, Ramachandran S. Vasan, Paul L. Kimmel, Chi-yuan Hsu, Kathleen D. Liu, for the CKD Biomarkers Consortium
CJASN Nov 2015, 10 (11) 1956-1963; DOI: 10.2215/CJN.02590315
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

Original Articles

  • Associations between Deprivation, Geographic Location, and Access to Pediatric Kidney Care in the United Kingdom
  • Variability in Culture-Negative Peritonitis Rates in Pediatric Peritoneal Dialysis Programs in the United States
  • Exome Chip Analyses and Genetic Risk for IgA Nephropathy among Han Chinese
Show more Original Articles

Epidemiology and Outcomes

  • Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study
  • Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986–2015
  • Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD
Show more Epidemiology and Outcomes

Cited By...

  • Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD
  • Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes
  • Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study
  • Lupus Nephritis in the Era of Biomarkers
  • Google Scholar

Similar Articles

Related Articles

  • PubMed
  • Google Scholar

Keywords

  • albuminuria
  • chronic kidney disease
  • end-stage renal disease
  • Acetylglucosaminidase
  • diabetes mellitus
  • Fatty Acid-Binding Proteins
  • kidney failure
  • chronic
  • lipocalins
  • renal insufficiency

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire